Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 1,106 shares at $9.57 ($11K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Scheduled sale ($11k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.57 | 706 | $7K | 62.0% |
| 2 | $10.34 | 400 | $4K | 38.0% |
| Total | $9.85 avg | 1,106 | $11K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-11 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |